ST3 β-Gal α-2,3-Sialyltransferase 5

Product Description: ST3 β-Gal α-2,3-Sialyltransferase 5 (ST3GAL5) is a glycosphingolipid (GSL) biosynthetic enzyme that can inhibit TGF-β-induced epithelial-mesenchymal transition (EMT), invasion, and metastasis both in vivo and in vitro. ST3 β-Gal α-2,3-Sialyltransferase 5 can be used in cancer research[1].

Formula: N/A

References: [1]Zhang J, et al. ST3GAL5-catalyzed gangliosides inhibit TGF-β-induced epithelial-mesenchymal transition via TβRI degradation. EMBO J. 2023 Jan 16;42(2):e110553.

Molecular Weight: N/A

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: TGF-beta/Smad

• Artikelnummer: MEXHY-E70299-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-E70299-1
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK